Report Detail
Global Meningococcal Vaccine Market Growth 2019-2024
- RnM2930467 |
- 12 February, 2019 |
- Global |
- 161 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.
The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.
According to this study, over the next five years the Meningococcal Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Meningococcal Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the Meningococcal Vaccine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Quadrivalent
Bivalent
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Meningococcal Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Meningococcal Vaccine market by identifying its various subsegments.
Focuses on the key global Meningococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Meningococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Meningococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Meningococcal Vaccine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Meningococcal Vaccine Consumption 2014-2024
- 2.1.2 Meningococcal Vaccine Consumption CAGR by Region
- 2.2 Meningococcal Vaccine Segment by Type
- 2.2.1 Quadrivalent
- 2.2.2 Bivalent
- 2.2.3 Others
- 2.3 Meningococcal Vaccine Consumption by Type
- 2.3.1 Global Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Meningococcal Vaccine Sale Price by Type (2014-2019)
- 2.4 Meningococcal Vaccine Segment by Application
- 2.4.1 Pneumonia
- 2.4.2 Meningitis
- 2.4.3 Bacteremia
- 2.4.4 Others (Arthritis, Conjunctivitis, Urethritis)
- 2.5 Meningococcal Vaccine Consumption by Application
- 2.5.1 Global Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Meningococcal Vaccine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Meningococcal Vaccine Sale Price by Application (2014-2019)
3 Global Meningococcal Vaccine by Players
- 3.1 Global Meningococcal Vaccine Sales Market Share by Players
- 3.1.1 Global Meningococcal Vaccine Sales by Players (2017-2019)
- 3.1.2 Global Meningococcal Vaccine Sales Market Share by Players (2017-2019)
- 3.2 Global Meningococcal Vaccine Revenue Market Share by Players
- 3.2.1 Global Meningococcal Vaccine Revenue by Players (2017-2019)
- 3.2.2 Global Meningococcal Vaccine Revenue Market Share by Players (2017-2019)
- 3.3 Global Meningococcal Vaccine Sale Price by Players
- 3.4 Global Meningococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Meningococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Meningococcal Vaccine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Meningococcal Vaccine by Regions
- 4.1 Meningococcal Vaccine by Regions
- 4.1.1 Global Meningococcal Vaccine Consumption by Regions
- 4.1.2 Global Meningococcal Vaccine Value by Regions
- 4.2 Americas Meningococcal Vaccine Consumption Growth
- 4.3 APAC Meningococcal Vaccine Consumption Growth
- 4.4 Europe Meningococcal Vaccine Consumption Growth
- 4.5 Middle East & Africa Meningococcal Vaccine Consumption Growth
5 Americas
- 5.1 Americas Meningococcal Vaccine Consumption by Countries
- 5.1.1 Americas Meningococcal Vaccine Consumption by Countries (2014-2019)
- 5.1.2 Americas Meningococcal Vaccine Value by Countries (2014-2019)
- 5.2 Americas Meningococcal Vaccine Consumption by Type
- 5.3 Americas Meningococcal Vaccine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Meningococcal Vaccine Consumption by Countries
- 6.1.1 APAC Meningococcal Vaccine Consumption by Countries (2014-2019)
- 6.1.2 APAC Meningococcal Vaccine Value by Countries (2014-2019)
- 6.2 APAC Meningococcal Vaccine Consumption by Type
- 6.3 APAC Meningococcal Vaccine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Meningococcal Vaccine by Countries
- 7.1.1 Europe Meningococcal Vaccine Consumption by Countries (2014-2019)
- 7.1.2 Europe Meningococcal Vaccine Value by Countries (2014-2019)
- 7.2 Europe Meningococcal Vaccine Consumption by Type
- 7.3 Europe Meningococcal Vaccine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Meningococcal Vaccine by Countries
- 8.1.1 Middle East & Africa Meningococcal Vaccine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Meningococcal Vaccine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Meningococcal Vaccine Consumption by Type
- 8.3 Middle East & Africa Meningococcal Vaccine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Meningococcal Vaccine Distributors
- 10.3 Meningococcal Vaccine Customer
11 Global Meningococcal Vaccine Market Forecast
- 11.1 Global Meningococcal Vaccine Consumption Forecast (2019-2024)
- 11.2 Global Meningococcal Vaccine Forecast by Regions
- 11.2.1 Global Meningococcal Vaccine Forecast by Regions (2019-2024)
- 11.2.2 Global Meningococcal Vaccine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Meningococcal Vaccine Forecast by Type
- 11.8 Global Meningococcal Vaccine Forecast by Application
12 Key Players Analysis
- 12.1 Novartis
- 12.1.1 Company Details
- 12.1.2 Meningococcal Vaccine Product Offered
- 12.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novartis News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 Meningococcal Vaccine Product Offered
- 12.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 Merck
- 12.3.1 Company Details
- 12.3.2 Meningococcal Vaccine Product Offered
- 12.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Merck News
- 12.4 CSL
- 12.4.1 Company Details
- 12.4.2 Meningococcal Vaccine Product Offered
- 12.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 CSL News
- 12.5 Baxter
- 12.5.1 Company Details
- 12.5.2 Meningococcal Vaccine Product Offered
- 12.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Baxter News
- 12.6 JN International Medical Corporation
- 12.6.1 Company Details
- 12.6.2 Meningococcal Vaccine Product Offered
- 12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 JN International Medical Corporation News
- 12.7 Serum Institute of India
- 12.7.1 Company Details
- 12.7.2 Meningococcal Vaccine Product Offered
- 12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Serum Institute of India News
- 12.8 Bio-Med
- 12.8.1 Company Details
- 12.8.2 Meningococcal Vaccine Product Offered
- 12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Bio-Med News
- 12.9 China National Biotec Group
- 12.9.1 Company Details
- 12.9.2 Meningococcal Vaccine Product Offered
- 12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 China National Biotec Group News
- 12.10 Hualan Bio
- 12.10.1 Company Details
- 12.10.2 Meningococcal Vaccine Product Offered
- 12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Hualan Bio News
- 12.11 Walvax
- 12.12 Zhifei
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Meningococcal Vaccine . Industry analysis & Market Report on Meningococcal Vaccine is a syndicated market report, published as Global Meningococcal Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Meningococcal Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
